RNXT
Price
$0.94
Change
+$0.02 (+2.17%)
Updated
Jul 6, 04:59 PM (EDT)
Capitalization
41.5M
38 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$3.96
Change
+$0.14 (+3.66%)
Updated
Jul 6 closing price
Capitalization
2.1B
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RNXT vs RXRX

RNXT vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
RNXT vs. RXRX commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNXT is a Buy and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2026
Stock price -- (RNXT: $0.92 vs. RXRX: $3.80)
Brand notoriety: RNXT and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNXT: 52% vs. RXRX: 123%
Market capitalization -- RNXT: $42.74M vs. RXRX: $2.1B
RNXT [@Biotechnology] is valued at $42.74M. RXRX’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $134.41B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNXT’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • RNXT’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both RNXT and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNXT’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • RNXT’s TA Score: 6 bullish, 4 bearish.
  • RXRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RNXT is a better buy in the short-term than RXRX.

Price Growth

RNXT (@Biotechnology) experienced а -5.14% price change this week, while RXRX (@Biotechnology) price change was +2.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.94%. For the same industry, the average monthly price growth was +11.46%, and the average quarterly price growth was +1972.07%.

Reported Earning Dates

RNXT is expected to report earnings on Aug 13, 2026.

RXRX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+0.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.1B) has a higher market cap than RNXT($41.5M). RNXT YTD gains are higher at: 9.523 vs. RXRX (-7.090). RNXT has higher annual earnings (EBITDA): -12.87M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. RNXT (12.4M). RNXT has less debt than RXRX: RNXT (186K) vs RXRX (72.4M). RXRX has higher revenues than RNXT: RXRX (65.7M) vs RNXT (1.49M).
RNXTRXRXRNXT / RXRX
Capitalization41.5M2.1B2%
EBITDA-12.87M-478.66M3%
Gain YTD9.523-7.090-134%
P/E RatioN/AN/A-
Revenue1.49M65.7M2%
Total Cash12.4M654M2%
Total Debt186K72.4M0%
TECHNICAL ANALYSIS
Technical Analysis
RNXTRXRX
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
83%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 6 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
RNXT
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDIB8.760.17
+1.98%
Reading International
FSSEX14.730.13
+0.89%
Fidelity SAI Sustainable Intl Eq
VTARX9.74-0.02
-0.20%
Virtus Tactical Allocation R6
ATHDX27.55-0.15
-0.54%
American Century Heritage R6
USSCX38.89-1.04
-2.60%
Victory Science & Technology

RNXT and

Correlation & Price change

A.I.dvisor tells us that RNXT and RXRX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and RXRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
-3.67%
RXRX - RNXT
31%
Poorly correlated
+3.54%
BEAM - RNXT
29%
Poorly correlated
+3.91%
SPRB - RNXT
29%
Poorly correlated
-0.07%
AVXL - RNXT
29%
Poorly correlated
+6.98%
MGNX - RNXT
28%
Poorly correlated
+1.95%
More